Improving ERCP quality and decreasing risk to patients and providers

Expert Review of Gastroenterology and Hepatology

Volumn 7, Issue 6, 2013, Pages 531-540

  Kachaamy, Toufic A ^a   Faigel, Douglas O ^a  

^a MAYO CLINIC   (United States)

Author keywords

endoscopic retrograde cholangiopancreatography; endoscopic sphincterotomy; hemorrhage; indomethacin; infection; intestinal perforation; pancreatitis; radiation; sedation; Stent

Indexed keywords

ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; INDOMETACIN; OPIATE; PROPOFOL;

ANTIBIOTIC PROPHYLAXIS; ASPIRATION PNEUMONIA; BALLOON DILATATION; BLEEDING; CARDIOVASCULAR DISEASE; CHOLANGITIS; CHOLECYSTITIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUS SEDATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENERAL ANESTHESIA; HEALTH CARE COST; HIGH VOLUME HOSPITAL; HUMAN; IMMUNOCOMPROMISED PATIENT; LEARNING CURVE; MEDICOLEGAL ASPECT; MORTALITY; PANCREATIC DUCT STENT; PANCREATITIS; PERFORATION; PRIMARY SCLEROSING CHOLANGITIS; RADIATION EXPOSURE; REVIEW; SPHINCTEROTOMY; TOTAL QUALITY MANAGEMENT;

BENCHMARKING; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CLINICAL COMPETENCE; HUMANS; LEARNING CURVE; OCCUPATIONAL EXPOSURE; PATIENT SAFETY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RADIATION PROTECTION; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84887853940     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2013.824703     Document Type: Review

References (66)

1. Cotton PB. Analysis of 59 ERCP lawsuits: mainly about indications. Gastrointest. Endosc. 63(3), 378-382 (2006). (Pubitemid 43261459)
2. Cotton PB. Twenty more ERCP lawsuits: why? Poor indications and communications. Gastrointest. Endosc. 72(4), 904 (2010).
3. Kapral C, Duller C, Wewalka F, Kerstan E, Vogel W, Schreiber F. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy 40(8), 625-630 (2008).
4. Freeman ML, Nelson DB, Sherman S et al. Complications of endoscopic biliary sphincterotomy N. Engl. J. Med. 355(13), 909-918 (1996). (Pubitemid 26314443)
5. Glomsaker T, Hoff G, Kvaløy JT, Søreide K, Aabakken L, Søreide JA. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br. J. Surg. 100(3), 373-380 (2013).
6. Enochsson L, Swahn F, Arnelo U et al. Nationwide, population-based data from 11,074 ERCP procedures from the Swedish Registry for Gallstone Surgery and ERCP. Gastrointest. Endosc. 72(6), 1175-1184 (2010).
7. Rice JP, Spier BJ, Gopal DV, Soni A, Reichelderfer M, Pfau PR. Outcomes of sphincter of Oddi manometry when performed in low volumes. Diagn. Ther. Endosc. 2011(2011), 435806-435806 (2011).
8. Guda NM, Freeman ML. Are you safe for your patients-how many ERCPs should you be doing? Endoscopy 40, 675-676 (2008).
9. Cotton PB, Eisen G, Romagnuolo J et al. Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest. Endosc. 73(8), 868-874 (2011).
10. Khashab MA, Tariq A, Tariq U et al. Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin. Gastroenterol. Hepatolo. 10(10), 1157-1161 (2012).
11. Chak A, Cooper GS, Lloyd LE, Hammar PJ, Issa K, Rosenthal GE. Effectiveness of ERCP in cholangitis: a community-based study. Gastrointest Endosc. 52(4), 484-489 (2000).
12. Boender J, Nix GA, de Ridder MA et al. Endoscopic sphincterotomy and biliary drainage in patients with cholangitis due to common bile duct stones. Am. J. Gastroenterol. 90(2), 233-238 (1995).
13. Nagino M, Takada T, Kawarada Y et al. Methods and timing of biliary drainage for acute cholangitis: Tokyo Guidelines. J. Hepatobiliary Pancreat. Surg. 14(1), 68-77 (2007). (Pubitemid 46189144)
14. Andriulli A, Loperfido S, Napolitano G, Niro G. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am. J. Gastroenterol. 102(8), 1781-1788 (2007). (Pubitemid 47206695)
15. Vandervoort J, Soetikno RM, Tham TC et al. Risk factors for complications after performance of ERCP. Gastrointest. Endosc. 56(5), 652-656 (2002). (Pubitemid 36531698)
16. Masci E, Toti G, Mariani A et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am. J. Gastro. 96(2), 417-423 (2001).
17. Andriulli A, Loperfido S, Napolitano G, Niro G. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am. J. Gastroenterol. 102(8), 1781-1788 (2007). (Pubitemid 47206695)
18. Raymondos K, Panning B, Bachem I et al. Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia. Endoscopy 34(9), 721-726 (2002). (Pubitemid 34965672)
19. Garewal D, Powell S, Milan SJ, Nordmeyer J, Waikar P. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst. Rev. 13(6), CD007274-CD007274 (2012).
20. Berzin TM, Sanaka S, Barnett SR et al. A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist administered sedation. Clin. Endosc. 73(4), 710-717 (2011).
21. Qadeer MA, Vargo JJ, Dumot JA et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology 136(5), 1568-1576 (2009).
22. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest. Endosc. 37(3), 383-393 (1991).
23. Testoni PA, Mariani A, Giussani A et al. Risk factors for post-ERCP pancreatitis in high-and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am. J. Gastroenterol. 105(8), 1753-1761 (2010).
24. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Clin. Endosc. 70(1), 80-88 (2009).
25. Mohammad A, Cotton PB, Hawes R et al. Techniques of pancreatic sphincterotomy: lack of expert consensus. Gastrointest. Endosc. 59(5), 210 (2004).
26. Cennamo V, Fuccio L, Zagari RM et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis? A meta-analysis of randomized controlled trials. Am J. Gastroenterol. 104(9), 2343-2350 (2009).
27. Verma D, Kapadia A, Adler DG. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest. Endosc. 66(2), 283-290 (2007). (Pubitemid 47079035)
28. Elta GH, Barnett JL, Wille RT, Brown KA, Chey WD, Scheiman JM. Pure cut electrocautery current for sphincterotomy. Gastrointest. Endosc. 47(2), 149-153 (1998).
29. Sherman S, Earle DT, Bucksot L et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study. Gastrointest. Endosc. 77(2), 209-216 (2013).
30. Tarnasky PR, Palesch YY, Cunningham JT et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115(6), 1518-1524 (1998). (Pubitemid 28546003)
31. Fazel A, Quadri A, Catalano MF et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest. Endosc. 57(3), 291-294 (2003). (Pubitemid 36350781)
32. Smithline A, Silverman W, Rogers D et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest. Endosc. 39(5), 652-657 (1993). (Pubitemid 23282518)
33. Patel R, Tarnasky P, Hennessy WS et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized controlled trial. Gastrointest. Endsosc. 57(3), 291-294 (2003).
34. Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest. Endosc. 62(3), 367-370 (2005). (Pubitemid 41187937)
35. Tsuchiya T, Itoi T, Sofuni A et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. J. Hepatobiliary Pancreat. Surg. 14(3), 302-307 (2007). (Pubitemid 46863921)
36. Sofuni A, Maguchi H, Itoi T et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin. Gastroenterol. Hepatol. 5(10), 1339-1346 (2007). (Pubitemid 350019054)
37. Choudhary A, Bechtold ML, Arif M et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest. Endosc. 73(2), 275-282 (2011).
38. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest. Endosc. 59(1), 8-14 (2004). (Pubitemid 38095500)
39. Elmunzer BJ, Scheiman JM, Lehman GA et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N. Engl. J. Med. 366(15), 1414-1422 (2012).
40. Kim HJ, Kim MH, Diet K et al. Endoscopic hemostasis in sphincterotomyinduced hemorrhage: its efficacy and safety. Endoscopy 31(6), 431-436 (1999). (Pubitemid 29412570)
41. Fujita N, Maguchi H, Komatsu Y et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial. Gastrointest. Endosc. 57(2), 151-155 (2003). (Pubitemid 36236749)
42. Disario JA, Freeman ML, Bjorkman DJ et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127(5), 1291-1299 (2004). (Pubitemid 39457755)
43. Liu Y, Su P, Lin S et al. Endoscopic papillary balloon dilatation versus endoscopic sphincterotomy in the treatment for choledocholithiasis: a meta-analysis. J. Gastroenterol. Hepatol. 27(3), 464-471 (2012).
44. Feng Y, Zhu H, Chen X et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a metaanalysis of randomized controlled trials. J. Gastroenterol. 47(6), 655-663 (2012).
45. Attam R, Freeman ML. Endoscopic papillary large balloon dilation for large common bile duct stones. J. Hepatobiliary Pancreat. Surg. 16(5), 618-623 (2009).
46. Fatima J, Baron TH, Topazian MD et al. Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures diagnosis and management. Arch. Surg. 142(5), 448-455 (2007).
47. Enns R, Eloubeidi MA, Mergener K et al. ERCP-related perforations: risk factors. and management. Endoscopy 34(4), 293-298 (2002). (Pubitemid 34279517)
48. Morgan KA, Fontenot BB, Ruddy JM, Mickey S, Adams DB. Endoscopic retrograde cholangiopancreatography gut perforations: when to wait! When to operate. Am. Surg. 75(6), 477-484 (2009).
49. Enns R, Eloubeidi MA, Mergener K et al. ERCP-related perforations: risk factors and management. Endoscopy 34(4), 293-298 (2002). (Pubitemid 34279517)
50. Machado NO. Management of duodenal perforation post-endoscopic retrograde cholangiopancreatography. When and whom to operate and what factors determine the outcome? A review article. JOP 13(1), 18-25 (2012).
51. Wu HM, Dixon E, May GR, Sutherland FR. Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review. HPB 8(5), 393-399 (2006). (Pubitemid 44473465)
52. Genzlinger JL, McPhee MS, Fisher JK, Jacob KM, Helzberg JH. Significance of retroperitoneal air after endoscopic retrograde cholangiopancreatography with sphincterotomy. Am. J. Gastroenterol. 94(5), 1267-1270 (1999). (Pubitemid 29214640)
53. Toner A, Garewal D, Keeling P. Safe anesthesia for ERCP. Anaesthesia 66(5), 390-402 (2011).
54. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 101(5), 1374-1381 (1991).
55. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest. Endosc. 47(5), 354-362 (1998). (Pubitemid 28237504)
56. Bangarulingam SY, Gossard AA, Petersen BT, Ott BJ, Lindor KD. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am. J. Gastroenterol. 104(4), 855-860 (2009).
57. Isayama H, Kawabe T, Nakai Y et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin. Gastroenterol. Hepatol. 4(9), 1148-1153 (2006). (Pubitemid 44311650)
58. Suk KT, Kim HS, Kim JW et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest. Endosc. 64(4), 522-529 (2006). (Pubitemid 44419412)
59. Banerjee S, Shen B, Baron TH et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest. Endosc. 67(6), 791-798 (2008).
60. Khashab MA, Tariq A, Tariq U et al. Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin. Gastroenterol. Hepatol. 10(10), 1157-1161 (2012).
61. Mettler FA, Bhargavan M, Faulkner K et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources 1950-2007. Radiology. 253(2), 520-531 (2009).
62. Valentin J. The 2007 Recommendations of the international commission on radiological protection. Ann. ICRP 37(2-4), 9-34 (2007).
63. Buls N, Pages J, Mana F et al. Patient and staff exposure during endoscopic retrograde cholangiopancreatography. Br. J. Radiol. 75(893), 435-443 (2002). (Pubitemid 34654081)
64. Baron TH, Petersen BT, Mergener K. Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest. Endosc. 63(4 Suppl), S29-S34 (2006).
65. Conklin LS, Bernstein C, Bartholomew L, Oliva-Hemker M. Medical malpractice in gastroenterology. Clin. Gastroenterol. Hepatol. 6(6), 677-681 (2008).
66. Cohen S, Bacon B, Berlin JA et al. National Institutes of Health state-of-the-science conference statement: ERCP for diagnosis and therapy. Gastrointest. Endosc. 56(6), 803-809 (2002). (Pubitemid 36236707)